Primary Anaplastic Lymphoma Kinase-Negative Breast Anaplastic Large Cell Lymphoma Without Breast Implant Association: A Case Report
- 1Department of Pathology, Bursa Uludag University Faculty of Medicine, Bursa, Türkiye
- 2Department of General Surgery, Bursa Uludag University Faculty of Medicine, Bursa, Türkiye
- 3Department of Radiology, Bursa Uludag University Faculty of Medicine, Bursa, Türkiye
Abstract
Background: Primary breast lymphomas are rare neoplasms, the majority of which are of B cell origin. Anaplastic large cell lymphoma of the breast is most commonly associated with breast implants; however, implant-unrelated tumors have also been reported. This case report describes a young patient diagnosed with primary anaplastic lymphoma kinase (ALK)-negative breast anaplastic large cell lymphoma in the absence of any history of breast implantation.
Case Report: A 26-year-old woman presented with right breast pain and a palpable mass that had persisted for 3 months. Radiological evaluation revealed a complex cystic lesion suspicious for malignancy. Histopathological examination of the core biopsy specimen demonstrated diffuse neoplastic infiltration composed of large atypical cells with marked nuclear pleomorphism and increased mitotic activity. Immunohistochemical analysis showed strong CD30 positivity and focal epithelial membrane antigen expression, while ALK, keratin AE1/AE3, CD20, and Epstein–Barr virus (EBV) were negative. Following breast-conserving surgery, the final diagnosis was ALK-negative anaplastic large cell lymphoma.
Conclusion: This report highlights that the development of anaplastic large cell lymphoma in the breast is not exclusively dependent on the presence of an implant and may occur in patients without any history of breast implantation. Given the nonspecific clinical and radiological findings, anaplastic large cell lymphoma should be considered in the differential diagnosis of breast masses, particularly those associated with cystic changes or chronic inflammatory processes. Definitive diagnosis requires thorough histopathological and immunophenotypic evaluation.
Related
- Extracavitary Primary Effusion Lymphoma in an HIV-Negative Patient With Aberrant Immunophenotypic Features.
- Bilateral breast implant-associated anaplastic large cell lymphoma presenting as late peri-implant effusion: a case report
- Complete remission with single agent lorlatinib in children with ALK+ anaplastic large cell lymphoma and central nervous system involvement: a case report
- Anaplastic Large Cell Lymphoma of the Brain Mimicking an Extra-Axial Frontal Tumor: A Case Report
- PRIMARY REFRACTORY EPSTEIN-BARR VIRUS-NEGATIVE PLASMABLASTIC LYMPHOMA IN AN IMMUNOCOMPETENT ADULT: A CASE REPORT
BibTeX
@article{ozsen2026primary,
title = {{Primary Anaplastic Lymphoma Kinase-Negative Breast Anaplastic Large Cell Lymphoma Without Breast Implant Association: A Case Report}},
author = {Mine Ozsen and Kazım Senol and Ulviye Yalcınkaya and Gokhan Gokalp},
journal = {International Journal of Surgical Pathology},
year = {2026},
month = may,
doi = {10.1177/10668969261448838},
url = {https://doi.org/10.1177/10668969261448838},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Primary Anaplastic Lymphoma Kinase-Negative Breast Anaplastic Large Cell Lymphoma Without Breast Implant Association: A Case Report
AU - Mine Ozsen
AU - Kazım Senol
AU - Ulviye Yalcınkaya
AU - Gokhan Gokalp
PY - 2026
DA - 2026/05/21
JO - International Journal of Surgical Pathology
DO - 10.1177/10668969261448838
UR - https://doi.org/10.1177/10668969261448838
AB - Background: Primary breast lymphomas are rare neoplasms, the majority of which are of B cell origin. Anaplastic large cell lymphoma of the breast is most commonly associated with breast implants; however, implant-unrelated tumors have also been reported. This case report describes a young patient diagnosed with primary anaplastic lymphoma kinase (ALK)-negative breast anaplastic large cell lymphoma in the absence of any history of breast implantation. Case Report: A 26-year-old woman presented with right breast pain and a palpable mass that had persisted for 3 months. Radiological evaluation revealed a complex cystic lesion suspicious for malignancy. Histopathological examination of the core biopsy specimen demonstrated diffuse neoplastic infiltration composed of large atypical cells with marked nuclear pleomorphism and increased mitotic activity. Immunohistochemical analysis showed strong CD30 positivity and focal epithelial membrane antigen expression, while ALK, keratin AE1/AE3, CD20, and Epstein–Barr virus (EBV) were negative. Following breast-conserving surgery, the final diagnosis was ALK-negative anaplastic large cell lymphoma. Conclusion: This report highlights that the development of anaplastic large cell lymphoma in the breast is not exclusively dependent on the presence of an implant and may occur in patients without any history of breast implantation. Given the nonspecific clinical and radiological findings, anaplastic large cell lymphoma should be considered in the differential diagnosis of breast masses, particularly those associated with cystic changes or chronic inflammatory processes. Definitive diagnosis requires thorough histopathological and immunophenotypic evaluation.
SN - 1066-8969
SN - 1940-2465
ER -